Topic resource collection
Approved comparison material connected to this topic.
7 resourcesRead both sides
To see where AICAR fits in the performance and fat-loss world, it helps to compare it with other popular compounds and the effects of traditional exercise. This context highlights what makes AICAR unique and where it can offer th…
MOTS-c is a 16-amino acid mitochondrial-derived peptide that also activates AMPK. Unlike AICAR, MOTS-c is an actual peptide, encoded by mitochondrial DNA and naturally produced in response to exercise. The activation pathway diff…
5-amino-1MQ is another compound of interest in metabolic research, though it works through NNMT inhibition rather than AMPK activation. While both compounds address metabolic dysfunction, they target different nodes in the metabo…
GW501516 is the other compound from the Salk Institute study. It works through PPARdelta activation rather than AMPK. While both are classified as exercise mimetics, they target different molecular pathways. In the original study…
SS-31 (elamipretide) targets mitochondria directly by stabilizing cardiolipin in the inner mitochondrial membrane. While AICAR tells cells to make more mitochondria through AMPK and PGC-1alpha signaling, SS-31 improves the functi…
Metformin, the most widely prescribed diabetes medication globally, also activates AMPK but through a completely different mechanism. Metformin inhibits complex I of the mitochondrial electron transport chain, which increases the…
AICAR does not exist in isolation. Multiple compounds target AMPK or produce exercise-mimetic effects. Understanding how AICAR compares to alternatives helps researchers make informed decisions.